FDA Returns Disappointing News for ALS Stem Cell Therapy
PLOS: DNA Science
OCTOBER 19, 2023
Also recently, FDA’s Cellular, Tissue, and Gene Therapies Advisory Committe turned down a stem cell treatment for amyotrophic lateral sclerosis, aka ALS, Lou Gehrig’s disease, or motor neuron disease. ALS is a disease of adulthood, beginning typically between 40 and 70 years of age. Most ALS cases are sporadic.
Let's personalize your content